a 2022

No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers

RADVAN, Martin; Martin KAMENÍK; Lumír KOC; Gabriela MATEJOVÁ; Eliška BARTEČKOVÁ et al.

Basic information

Original name

No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers

Authors

RADVAN, Martin; Martin KAMENÍK; Lumír KOC; Gabriela MATEJOVÁ; Eliška BARTEČKOVÁ; Jana HOŘÍNKOVÁ; Radka ŠTĚPÁNOVÁ and Petr KALA

Edition

ESC Congress 2022 - Barcelona, Spain 26–29 August 2022, 2022

Other information

Type of outcome

Konferenční abstrakta

Confidentiality degree

is not subject to a state or trade secret

References:

URL

Marked to be transferred to RIV

No

Organization

Lékařská fakulta – Repository – Repository

Links

LX22NPO5107, research and development project.
Changed: 17/1/2023 03:52, RNDr. Daniel Jakubík

Abstract

In the original language

lt;0.001) between V1 a V3, a mild enlargement of left atrium (37.1±5.85 to 38.2±5.65mm; p=0,021) and nonsignificant trend to impairment of left ventricle diastolic dysfunction. There was a mild change of pulmonary artery systolic pressure (24.7±7.92 to 27.5±6.97mmHg; p=0,038). Conclusion: Despite many information regarding cardiac impairment of SARS-CoV-2 our study does not suggest increased risk of development of heart failure during the one year follow-up. Based on our results the routine echocardiography and biomarkers collection is currently not recommended after COVID-19 recovery.
Displayed: 9/5/2026 06:00